Fanconi Anemia Market Growth Driven by Genetic Research and Healthcare Investments**Fanconi Anemia (FA) is a rare genetic disorder impacting bone marrow's ability to produce blood cells, leading to ...

The gene editing tool known as CRISPR-Cas9 is changing what's possible for treating a wide range of diseases caused by ...

The U.S. Cellular Reprogramming Tools Market is entering a high-growth decade, projected to expand from USD 446.8 million in ...

CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the best gene-editing stocks to buy according to hedge funds. On November 11, ...

Editas strengthened its balance sheet by raising $17.8 million through its ATM (at-the-market) offering in the third quarter ...

A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child ...

Penn and CHOP researchers will utilize the new protocol to distribute customizable drugs that target specific genetic disorders.

AutismInDogs #GeneEditing #CRISPR #AlzheimersPrediction #ArtificialIntelligence Have you ever looked into the face of evil?

Enkhuizen, the Netherlands, and Durham, North Carolina, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Enza Zaden, a global leader in vegetable breeding that develops and supplies innovative vegetable seeds for ...

ChristianaCare’s Gene Editing Institute says it has found a way to reverse chemotherapy resistance in one of the most common ...

In a major step forward for cancer care, researchers at ChristianaCare’s Gene Editing Institute have shown that disabling the ...